Global Veterinary Artificial Reproduction Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08251371

Publication Date:

August 4, 2025

Pages:

133

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

According to this study, the global Veterinary Artificial Reproduction market size will reach US$ 5708 million by 2031.
Veterinary artificial reproduction refers to the set of assisted reproductive technologies (ART) used in animals to achieve conception without natural mating. Common techniques include artificial insemination (AI), in vitro fertilization (IVF), embryo transfer (ET), ovum pick-up (OPU), and cloning. These methods are widely applied in livestock breeding, genetic improvement, companion animal reproduction, conservation of endangered species, and laboratory animal production. Veterinary ART enhances reproductive efficiency, accelerates genetic progress, and minimizes disease transmission, making it a critical tool in modern animal health and production systems.
United States market for Veterinary Artificial Reproduction is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Veterinary Artificial Reproduction is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Veterinary Artificial Reproduction is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Veterinary Artificial Reproduction players cover Zoetis, Genus, Merck Animal Health, CRV, URUS Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淰eterinary Artificial Reproduction Industry Forecast鈥� looks at past sales and reviews total world Veterinary Artificial Reproduction sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Artificial Reproduction sales for 2025 through 2031. With Veterinary Artificial Reproduction sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Artificial Reproduction industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Artificial Reproduction landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Artificial Reproduction portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Veterinary Artificial Reproduction market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Artificial Reproduction and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Artificial Reproduction.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Artificial Reproduction market by product type, application, key players and key regions and countries.
Segmentation by Type:
Artificial Insemination
In Vitro Fertilization
Embryo Transfer
Other
Segmentation by Application:
Livestock
Companion Animal
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Genus
Merck Animal Health
CRV
URUS Group
ABS Global
Semex
Boehringer Ingelheim
Virbac
JSR Genetics
HerdX
Taurus
Nandi Genetics
Geno
AgriBio
CAHIC
Ruipu Biotech
Dahuanong

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary Artificial Reproduction Market Size (2020-2031)
2.1.2 Veterinary Artificial Reproduction Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Veterinary Artificial Reproduction by Country/Region (2020, 2024 & 2031)
2.2 Veterinary Artificial Reproduction Segment by Type
2.2.1 Artificial Insemination
2.2.2 In Vitro Fertilization
2.2.3 Embryo Transfer
2.2.4 Other
2.3 Veterinary Artificial Reproduction Market Size by Type
2.3.1 Veterinary Artificial Reproduction Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Veterinary Artificial Reproduction Market Size Market Share by Type (2020-2025)
2.4 Veterinary Artificial Reproduction Segment by Application
2.4.1 Livestock
2.4.2 Companion Animal
2.5 Veterinary Artificial Reproduction Market Size by Application
2.5.1 Veterinary Artificial Reproduction Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Veterinary Artificial Reproduction Market Size Market Share by Application (2020-2025)
3 Veterinary Artificial Reproduction Market Size by Player
3.1 Veterinary Artificial Reproduction Market Size Market Share by Player
3.1.1 Global Veterinary Artificial Reproduction Revenue by Player (2020-2025)
3.1.2 Global Veterinary Artificial Reproduction Revenue Market Share by Player (2020-2025)
3.2 Global Veterinary Artificial Reproduction Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Veterinary Artificial Reproduction by Region
4.1 Veterinary Artificial Reproduction Market Size by Region (2020-2025)
4.2 Global Veterinary Artificial Reproduction Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Artificial Reproduction Market Size Growth (2020-2025)
4.4 APAC Veterinary Artificial Reproduction Market Size Growth (2020-2025)
4.5 Europe Veterinary Artificial Reproduction Market Size Growth (2020-2025)
4.6 Middle East & Africa Veterinary Artificial Reproduction Market Size Growth (2020-2025)
5 Americas
5.1 Americas Veterinary Artificial Reproduction Market Size by Country (2020-2025)
5.2 Americas Veterinary Artificial Reproduction Market Size by Type (2020-2025)
5.3 Americas Veterinary Artificial Reproduction Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Artificial Reproduction Market Size by Region (2020-2025)
6.2 APAC Veterinary Artificial Reproduction Market Size by Type (2020-2025)
6.3 APAC Veterinary Artificial Reproduction Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Veterinary Artificial Reproduction Market Size by Country (2020-2025)
7.2 Europe Veterinary Artificial Reproduction Market Size by Type (2020-2025)
7.3 Europe Veterinary Artificial Reproduction Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary Artificial Reproduction by Region (2020-2025)
8.2 Middle East & Africa Veterinary Artificial Reproduction Market Size by Type (2020-2025)
8.3 Middle East & Africa Veterinary Artificial Reproduction Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Veterinary Artificial Reproduction Market Forecast
10.1 Global Veterinary Artificial Reproduction Forecast by Region (2026-2031)
10.1.1 Global Veterinary Artificial Reproduction Forecast by Region (2026-2031)
10.1.2 Americas Veterinary Artificial Reproduction Forecast
10.1.3 APAC Veterinary Artificial Reproduction Forecast
10.1.4 Europe Veterinary Artificial Reproduction Forecast
10.1.5 Middle East & Africa Veterinary Artificial Reproduction Forecast
10.2 Americas Veterinary Artificial Reproduction Forecast by Country (2026-2031)
10.2.1 United States Market Veterinary Artificial Reproduction Forecast
10.2.2 Canada Market Veterinary Artificial Reproduction Forecast
10.2.3 Mexico Market Veterinary Artificial Reproduction Forecast
10.2.4 Brazil Market Veterinary Artificial Reproduction Forecast
10.3 APAC Veterinary Artificial Reproduction Forecast by Region (2026-2031)
10.3.1 China Veterinary Artificial Reproduction Market Forecast
10.3.2 Japan Market Veterinary Artificial Reproduction Forecast
10.3.3 Korea Market Veterinary Artificial Reproduction Forecast
10.3.4 Southeast Asia Market Veterinary Artificial Reproduction Forecast
10.3.5 India Market Veterinary Artificial Reproduction Forecast
10.3.6 Australia Market Veterinary Artificial Reproduction Forecast
10.4 Europe Veterinary Artificial Reproduction Forecast by Country (2026-2031)
10.4.1 Germany Market Veterinary Artificial Reproduction Forecast
10.4.2 France Market Veterinary Artificial Reproduction Forecast
10.4.3 UK Market Veterinary Artificial Reproduction Forecast
10.4.4 Italy Market Veterinary Artificial Reproduction Forecast
10.4.5 Russia Market Veterinary Artificial Reproduction Forecast
10.5 Middle East & Africa Veterinary Artificial Reproduction Forecast by Region (2026-2031)
10.5.1 Egypt Market Veterinary Artificial Reproduction Forecast
10.5.2 South Africa Market Veterinary Artificial Reproduction Forecast
10.5.3 Israel Market Veterinary Artificial Reproduction Forecast
10.5.4 Turkey Market Veterinary Artificial Reproduction Forecast
10.6 Global Veterinary Artificial Reproduction Forecast by Type (2026-2031)
10.7 Global Veterinary Artificial Reproduction Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Veterinary Artificial Reproduction Forecast
11 Key Players Analysis
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Veterinary Artificial Reproduction Product Offered
11.1.3 Zoetis Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Zoetis Main Business Overview
11.1.5 Zoetis Latest Developments
11.2 Genus
11.2.1 Genus Company Information
11.2.2 Genus Veterinary Artificial Reproduction Product Offered
11.2.3 Genus Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Genus Main Business Overview
11.2.5 Genus Latest Developments
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Information
11.3.2 Merck Animal Health Veterinary Artificial Reproduction Product Offered
11.3.3 Merck Animal Health Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merck Animal Health Main Business Overview
11.3.5 Merck Animal Health Latest Developments
11.4 CRV
11.4.1 CRV Company Information
11.4.2 CRV Veterinary Artificial Reproduction Product Offered
11.4.3 CRV Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 CRV Main Business Overview
11.4.5 CRV Latest Developments
11.5 URUS Group
11.5.1 URUS Group Company Information
11.5.2 URUS Group Veterinary Artificial Reproduction Product Offered
11.5.3 URUS Group Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 URUS Group Main Business Overview
11.5.5 URUS Group Latest Developments
11.6 ABS Global
11.6.1 ABS Global Company Information
11.6.2 ABS Global Veterinary Artificial Reproduction Product Offered
11.6.3 ABS Global Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 ABS Global Main Business Overview
11.6.5 ABS Global Latest Developments
11.7 Semex
11.7.1 Semex Company Information
11.7.2 Semex Veterinary Artificial Reproduction Product Offered
11.7.3 Semex Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Semex Main Business Overview
11.7.5 Semex Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Veterinary Artificial Reproduction Product Offered
11.8.3 Boehringer Ingelheim Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Veterinary Artificial Reproduction Product Offered
11.9.3 Virbac Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Virbac Main Business Overview
11.9.5 Virbac Latest Developments
11.10 JSR Genetics
11.10.1 JSR Genetics Company Information
11.10.2 JSR Genetics Veterinary Artificial Reproduction Product Offered
11.10.3 JSR Genetics Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 JSR Genetics Main Business Overview
11.10.5 JSR Genetics Latest Developments
11.11 HerdX
11.11.1 HerdX Company Information
11.11.2 HerdX Veterinary Artificial Reproduction Product Offered
11.11.3 HerdX Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 HerdX Main Business Overview
11.11.5 HerdX Latest Developments
11.12 Taurus
11.12.1 Taurus Company Information
11.12.2 Taurus Veterinary Artificial Reproduction Product Offered
11.12.3 Taurus Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Taurus Main Business Overview
11.12.5 Taurus Latest Developments
11.13 Nandi Genetics
11.13.1 Nandi Genetics Company Information
11.13.2 Nandi Genetics Veterinary Artificial Reproduction Product Offered
11.13.3 Nandi Genetics Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Nandi Genetics Main Business Overview
11.13.5 Nandi Genetics Latest Developments
11.14 Geno
11.14.1 Geno Company Information
11.14.2 Geno Veterinary Artificial Reproduction Product Offered
11.14.3 Geno Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Geno Main Business Overview
11.14.5 Geno Latest Developments
11.15 AgriBio
11.15.1 AgriBio Company Information
11.15.2 AgriBio Veterinary Artificial Reproduction Product Offered
11.15.3 AgriBio Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 AgriBio Main Business Overview
11.15.5 AgriBio Latest Developments
11.16 CAHIC
11.16.1 CAHIC Company Information
11.16.2 CAHIC Veterinary Artificial Reproduction Product Offered
11.16.3 CAHIC Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 CAHIC Main Business Overview
11.16.5 CAHIC Latest Developments
11.17 Ruipu Biotech
11.17.1 Ruipu Biotech Company Information
11.17.2 Ruipu Biotech Veterinary Artificial Reproduction Product Offered
11.17.3 Ruipu Biotech Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Ruipu Biotech Main Business Overview
11.17.5 Ruipu Biotech Latest Developments
11.18 Dahuanong
11.18.1 Dahuanong Company Information
11.18.2 Dahuanong Veterinary Artificial Reproduction Product Offered
11.18.3 Dahuanong Veterinary Artificial Reproduction Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Dahuanong Main Business Overview
11.18.5 Dahuanong Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂